Conavi Medical Corp.
CNVIF
$0.3238
-$0.0031-0.95%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -84.48% | -90.75% | 560.43% | -75.89% | 257.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -84.48% | -90.75% | 560.43% | -75.89% | 257.88% |
| Cost of Revenue | -99.79% | -113.33% | 17.92% | -25.18% | 291.82% |
| Gross Profit | 205.66% | 667.42% | 9,257.97% | -97.43% | -1,045.95% |
| SG&A Expenses | -44.36% | -6.49% | 5.18% | 4.49% | 45.88% |
| Depreciation & Amortization | -9.56% | -24.43% | -24.11% | -24.82% | -29.72% |
| Other Operating Expenses | -- | -- | 18.77% | 23.94% | -- |
| Total Operating Expenses | -50.09% | -22.24% | 8.45% | -12.15% | 45.13% |
| Operating Income | 48.54% | 15.53% | 55.07% | -9.59% | -41.34% |
| Income Before Tax | 72.97% | 58.71% | 31.90% | -124.18% | -109.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 72.97% | 58.71% | 31.90% | -124.18% | -109.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.97% | 58.71% | 31.90% | -124.18% | -109.98% |
| EBIT | 48.54% | 15.53% | 55.07% | -9.59% | -41.34% |
| EBITDA | 48.98% | 14.63% | 55.64% | -9.50% | -44.96% |
| EPS Basic | 97.57% | 94.25% | 90.05% | -123.82% | -109.87% |
| Normalized Basic EPS | 95.93% | 89.25% | 84.04% | -31.05% | -67.79% |
| EPS Diluted | 97.57% | 94.25% | 90.05% | -123.82% | -109.87% |
| Normalized Diluted EPS | 95.93% | 89.25% | 84.04% | -31.05% | -67.79% |
| Average Basic Shares Outstanding | 1,012.79% | 618.64% | 584.65% | 0.15% | 0.05% |
| Average Diluted Shares Outstanding | 1,012.79% | 618.64% | 584.65% | 0.15% | 0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |